Dynamic gene expression patterns in animal models of early and late heart failure reveal biphasic-bidirectional transcriptional activation of signaling pathways

Physiological Genomics

Volumn 46, Issue 20, 2014, Pages 779-787

  Rowell, Janelle ^a   Koitabashi, Norimichi ^a   Kass, David A ^a   Barth, Andreas S ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Gene expression; Genomics; Heart failure; Meta analysis; Signaling pathways

Indexed keywords

ADENOSINE A2A RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; ESTROGEN RELATED RECEPTOR ALPHA; GA BINDING PROTEIN; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; MICRORNA; MICRORNA 1; MICRORNA 133A; MICRORNA 133B; MICRORNA 150; MICRORNA 22; MICRORNA 499; MICRORNA 9; MITOGEN ACTIVATED PROTEIN KINASE; MYOCYTE ENHANCER FACTOR 2; MYOSIN LIGHT CHAIN 2; PHOSPHOLIPASE C BETA1; PROTEIN KINASE C; PROTEIN P53; SUCCINATE DEHYDROGENASE; SUCCINATE DEHYDROGENASE COMPLEX C; TRANSCRIPTION FACTOR ELF 1; TRANSCRIPTION FACTOR ETS 2; TRANSFORMING GROWTH FACTOR BETA; TROPONIN C; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG; TRANSCRIPTION FACTOR; TRANSCRIPTOME;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CALCIUM SIGNALING; CITRIC ACID CYCLE; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; EXPERIMENTAL DOG; FATTY ACID METABOLISM; FOCAL ADHESION; GENE EXPRESSION; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLYCOLYSIS; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SUCROSE METABOLISM; TRANSCRIPTION INITIATION; UPREGULATION; VASCULAR SMOOTH MUSCLE; ANIMAL; BINDING SITE; BIOLOGICAL MODEL; C57BL MOUSE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; TIME;

ANIMALS; BINDING SITES; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION REGULATION; HEART FAILURE; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MICE, INBRED C57BL; MODELS, CARDIOVASCULAR; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TRANSCRIPTOME; UP-REGULATION;

EID: 84907962989     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00054.2014     Document Type: Article

References (37)

1. Bagnall RD, Tsoutsman T, Shephard RE, Ritchie W, Semsarian C. Global microRNA profiling of the mouse ventricles during development of severe hypertrophic cardiomyopathy and heart failure. PLoS One 7: e44744, 2012.
2. Barth AS, Kumordzie A, Colantuoni C, Margulies KB, Cappola TP, Tomaselli GF. Reciprocal regulation of metabolic and signaling pathways. BMC Genomics 11: 197, 2010.
3. Barth AS, Kumordzie A, Frangakis C, Margulies KB, Cappola TP, Tomaselli GF. Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure. Circ Cardiovasc Genet 4: 475–483, 2011.
4. Van den Bosch BJC, Lindsey PJ, van den Burg CMM, van der Vlies SA, Lips DJ, van der Vusse GJ, Ayoubi TA, Doevendans PA, Smeets HJM. Early and transient gene expression changes in pressure overload-induced cardiac hypertrophy in mice. Genomics 88: 480–488, 2006.
5. Cheng Y, Ji R, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C. MicroRNAs are aberrantly expressed in hypertrophic heart: do they play a role in cardiac hypertrophy? Am J Pathol 170: 1831–1840, 2007.
6. Cui Q, Yu Z, Pan Y, Purisima EO, Wang E. MicroRNAs preferentially target the genes with high transcriptional regulation complexity. Biochem Biophys Res Commun 352: 733–738, 2007.
7. Czubryt MP, McAnally J, Fishman GI, Olson EN. Regulation of peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) and mitochondrial function by MEF2 and HDAC5. Proc Natl Acad Sci USA 100: 1711–1716, 2003.
8. Edgar R, Domrachev M, Lash AE. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30: 207–210, 2002.
9. Ertel A, Tozeren A. Switch-like genes populate cell communication pathways and are enriched for extracellular proteins. BMC Genomics 9: 3, 2008.
10. Gao Z, Barth AS, DiSilvestre D, Akar FG, Tian Y, Tanskanen A, Kass DA, Winslow RL, Tomaselli GF. Key pathways associated with heart failure development revealed by gene networks correlated with cardiac remodeling. Physiol Genomics 35: 222–230, 2008.
11. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, Bravata DM, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Magid D, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Nichol G, Paynter NP, Schreiner PJ, Sorlie PD, Stein J, Turan TN, Virani SS, Wong ND, Woo D, Turner MB. Executive summary: heart disease and stroke statistics-2013 update: a report from the American Heart Association. Circulation 127: 143–152, 2013.
12. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4: 44–57, 2009.
13. Huang HC, Jupiter D, VanBuren V. Classification of genes and putative biomarker identification using distribution metrics on expression profiles. PLoS One 5: e9056, 2010.
14. Huss JM, Imahashi K, Dufour CR, Weinheimer CJ, Courtois M, Kovacs A, Giguère V, Murphy E, Kelly DP. The nuclear receptor ERRalpha is required for the bioenergetic and functional adaptation to cardiac pressure overload. Cell Metab 6: 25–37, 2007.
15. Ikeda S, Kong SW, Lu J, Bisping E, Zhang H, Allen PD, Golub TR, Pieske B, Pu WT. Altered microRNA expression in human heart disease. Physiol Genomics 31: 367–373, 2007.
16. Kanehisa M, Goto S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28: 27–30, 2000.
17. Koitabashi N, Bedja D, Zaiman AL, Pinto YM, Zhang M, Gabrielson KL, Takimoto E, Kass DA. Avoidance of transient cardiomyopathy in cardiomyocyte-targeted tamoxifen-induced MerCreMer gene deletion models. Circ Res 105: 12–15, 2009.
18. Liu MS, Liu CH, Wu G, Zhou Y. Antisense inhibition of secretory and cytosolic phospholipase A2 reduces the mortality in rats with sepsis*. Crit Care Med 40: 2132–2140, 2012.
19. Liu MS, Yang RC, Hsu C, Chen YH, Liu CH, Zhou Y. Changes in group II phospholipase A2 gene expression in rat heart during sepsis. J Surg Res 181: 272–278, 2013.
20. Müller FU, Eschenhagen T, Reidemeister A, Schmitz W, Scholz H. In vivo beta-adrenergic stimulation leads to biphasic regulation of Gi alpha-2 gene transcriptional activity in rat heart. J Mol Cell Cardiol 26: 869–875, 1994.
21. Naseem RH, Meeson AP, Michael Dimaio J, White MD, Kallhoff J, Humphries C, Goetsch SC, De Windt LJ, Williams MA, Garry MG, Garry DJ. Reparative myocardial mechanisms in adult C57BL/6 and MRL mice following injury. Physiol Genomics 30: 44–52, 2007.
22. Naya FJ, Black BL, Wu H, Bassel-Duby R, Richardson JA, Hill JA, Olson EN. Mitochondrial deficiency and cardiac sudden death in mice lacking the MEF2A transcription factor. Nat Med 8: 1303–1309, 2002.
23. Ojaimi C, Qanud K, Hintze TH, Recchia FA. Altered expression of a limited number of genes contributes to cardiac decompensation during chronic ventricular tachypacing in dogs. Physiol Genomics 29: 76-83, 2007.
24. Prévilon M, Pezet M, Dachez C, Mercadier JJ, Rouet-Benzineb P. Sequential alterations in Akt, GSK3fj, and calcineurin signalling in the mouse left ventricle after thoracic aortic constriction. Can J Physiol Pharmacol 88: 1093-1101, 2010.
25. Van Rooij E, Sutherland LB, Liu N, Williams AH, McAnally J, Gerard RD, Richardson JA, Olson EN. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 103: 18255-18260, 2006.
26. Sayed D, Hong C, Chen IY, Lypowy J, Abdellatif M. MicroRNAs play an essential role in the development of cardiac hypertrophy. Circ Res 100: 416–424, 2007.
27. Sen S, Kundu BK, Wu HCJ, Hashmi SS, Guthrie P, Locke LW, Roy RJ, Matherne GP, Berr SS, Terwelp M, Scott B, Carranza S, Frazier OH, Glover DK, Dillmann WH, Gambello MJ, Entman ML, Taegt-meyer H. Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart. J Am Heart Assoc 2: e004796, 2013.
28. Sihag S, Cresci S, Li AY, Sucharov CC, Lehman JJ. PGC-1alpha and ERRalpha target gene downregulation is a signature of the failing human heart. J Mol Cell Cardiol 46: 201-212, 2009.
29. Sturn A, Quackenbush J, Trajanoski Z. Genesis: cluster analysis of microarray data. Bioinformatics 18: 207-208, 2002.
30. Taegtmeyer H, Sen S, Vela D. Return to the fetal gene program: a suggested metabolic link to gene expression in the heart. Ann NY Acad Sci 1188: 191-198, 2010.
31. Tarnavski O, McMullen JR, Schinke M, Nie Q, Kong S, Izumo S. Mouse cardiac surgery: comprehensive techniques for the generation of mouse models of human diseases and their application for genomic studies. Physiol Genomics 16: 349-360, 2004.
32. Tatsuguchi M, Seok HY, Callis TE, Thomson JM, Chen JF, Newman M, Rojas M, Hammond SM, Wang DZ. Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 42: 1137-1141, 2007.
33. Tong LJ, Dong LW, Hsu HK, Liu MS. Phospholipase A2 activities are decreased during early but increased during late phases of sepsis in rat heart. J Surg Res 75: 165-169, 1998.
34. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 98: 5116-5121, 2001.
35. Ueno S, Ohki R, Hashimoto T, Takizawa T, Takeuchi K, Yamashita Y, Ota J, Choi YL, Wada T, Koinuma K, Yamamoto K, Ikeda U, Shimada K, Mano H. DNA microarray analysis of in vivo progression mechanism of heart failure. Biochem Biophys Res Commun 307: 771–777, 2003.
36. Wang J, Duncan D, Shi Z, Zhang B. WEB-based GEne SeT AnaLysis Toolkit (WebGestalt): update 2013. Nucleic Acids Res 41: W77-W83, 2013.
37. Zhao M, Chow A, Powers J, Fajardo G, Bernstein D. Mcroarray analysis of gene expression after transverse aortic constriction in mice. Physiol Genomics 19: 93-105, 2004.